Frenzel Oliver C, Eukel Heidi, Skoy Elizabeth, Werremeyer Amy, Steig Jayme, Strand Mark
North Dakota State University, School of Pharmacy.
Quality Health Associates of North Dakota.
Innov Pharm. 2020 Oct 29;11(4). doi: 10.24926/iip.v11i4.3446. eCollection 2020.
A statewide opioid risk screening program was introduced to pharmacists to provide them with resources to screen patients who are prescribed an opioid medication. Using opioid risk screening equips pharmacists to deliver education and patient-centered interventions for opioid harm reduction. Nearly 50% of pharmacists that enrolled their pharmacy to participate in this program did not actively implement the program to patients. Little research is dedicated to examining factors which contribute to unsuccessful implementation of pharmacy-centered interventions. This research aims to describe barriers and beliefs which may hinder the ability of pharmacists to integrate innovative practices into existing workflow.
Using the theory of planned behavior, determine what attitudes and beliefs contribute to unsuccessful implementation of opioid risk screening.
A survey was developed within the context of a theoretical framework and distributed to pharmacists who did not successfully implement opioid risk screening 12 month following program inception. Attitude, subjective norm, and perceived behavioral control constructs of the theory of planned behavior were used to identify barriers to opioid risk screening implementation. The responses were analyzed using Mann-Whitney U test, ANOVA, and descriptive statistics.
Twenty-three pharmacists consented to participate in this study and 17 pharmacists completed the survey (response rate 74%). Pharmacists indicated positive attitudes toward reducing negative opioid outcomes for patients using opioid medications. Positive subjective norm responses indicated a perception that patients and collaborative healthcare providers would approve of pharmacists using opioid risk screening for patients. The highest proportion of negative responses was observed in the perceived behavioral control construct which included difficulty in offering the screening and unsuccessful integration of past interventions.
These results suggest that perceived behavioral control of pharmacists is the most influential factor in unsuccessful implementation of opioid risk screening.
一项全州范围的阿片类药物风险筛查计划已向药剂师推出,为他们提供资源,以便对开具阿片类药物处方的患者进行筛查。使用阿片类药物风险筛查使药剂师能够提供教育和以患者为中心的干预措施,以减少阿片类药物危害。近50%登记参与该计划的药剂师并未积极对患者实施该计划。很少有研究致力于探讨导致以药房为中心的干预措施实施不成功的因素。本研究旨在描述可能阻碍药剂师将创新实践融入现有工作流程的障碍和信念。
运用计划行为理论,确定哪些态度和信念导致阿片类药物风险筛查实施不成功。
在一个理论框架内设计了一项调查,并分发给在项目启动后12个月内未成功实施阿片类药物风险筛查的药剂师。计划行为理论的态度、主观规范和感知行为控制结构被用于识别阿片类药物风险筛查实施的障碍。使用曼-惠特尼U检验、方差分析和描述性统计对回复进行分析。
23名药剂师同意参与本研究,17名药剂师完成了调查(回复率74%)。药剂师对减少使用阿片类药物患者的负面阿片类药物结果表示积极态度。积极的主观规范回复表明,他们认为患者和合作医疗服务提供者会赞成药剂师对患者进行阿片类药物风险筛查。在感知行为控制结构中观察到的负面回复比例最高,其中包括难以提供筛查以及过去的干预措施未能成功整合。
这些结果表明,药剂师的感知行为控制是阿片类药物风险筛查实施不成功的最有影响力的因素。